
Featured market report: 3D printing market summary
pharmafile | November 2, 2015 | Feature | Manufacturing and Production |Â Â 3d printing, manufacturing, medical devices, productionÂ
The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.
The 3D printing market is set for unprecented growth: driven by factors such as continuous technological advancements in 3D printing, rising government financial support to develop novel healthcare applications of 3D printing technology, ability to develop customized medical products using 3D printing technology, and growing acceptance of 3D-printed organs in organ transplantation surgeries.
The repor, from leading industry analysts MarketandMarkets, provides data on:
• Market penetration: Comprehensive information on 3D printing products and services offered by the top 10 players in the 3D printing medical devices market
• The 3D printing medical devices market by component, technology, and medical products, across four geographies
• Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements
• New product launches in the 3D printing medical devices market
• Market Development: Comprehensive information about lucrative emerging markets
• Analysis of the markets for various 3D printing equipment, materials, and services and software, across four geographies
• Competitive assessment: In-depth assessment of market shares, strategies, products, distribution networks
• Manufacturing capabilities of leading players in the 3D printing medical devices market.
For more information, and to purchase the report, click here.
Related Content

Brenntag and dsm-firmenich expand biopharma vitamin partnership
Brenntag Pharma and dsm-firmenich have entered a long-term global distribution partnership covering GMP-grade vitamins for …

BioDuro establishes joint manufacturing venture with Cenra
BioDuro, a Contract Research, Development and Manufacturing Organisation (CRDMO), has established a joint venture with …

CARBOGEN AMCIS manufacturing license advances services in China
Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …





